Company: NDRA
Filing Date: 2025-03-31
Form Type: 8-K
Source: 0001654954-25-003611
Chunk: 2

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                              
         99.1      Press Release dated March 31, 2025, furnished herewith.  
         99.2      Press Release dated March 31, 2025, furnished herewith.  
 ────────────────────────────────────────────────────────────────────────────

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ENDRA Life Sciences Inc.                               
  March 31, 2025                                         
  By:                           /s/ Richard Jacroux      
  Name:                         Richard Jacroux          
  Title:                        Chief Financial Officer  

   3